|Videos|February 27, 2023
Ascendia Pharmaceuticals - Sophisticated Formulations from Molecule to Formulation to Clinical
Author(s)Ascendia Pharma
Key Learning Objectives
- Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules
- Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial and commercial manufacturing
- Ascendia is expanding its manufacturing capability to best serve customers and continue to be Partner of Choice for many of them
Related Content
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
2
FDA Activity Round Up – July 2026
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5